2019 - 6 Issue

Case report

Ocular Symptoms of Rosacea

Full Text links

Summary

The authors present case reports of two women, who were hospitalized in Department of Ophthalmology, University hospital Hradec Králové for ocular symptoms of rosacea. In the beginning there were relatively severe objective findings in the anterior segment of the eye in both cases – significant cornea graying with superficial and deep cornea vascularization in both eyes. On faces of both patients there were more or less typical sings of general illness. Especially in the first case there were severe papulopustules with crust all over the face. Subjectively Patients describe characteristic symptoms of dry eye. After dermatological consultation local and general anti-inflammatory treatment was set with consequent condition improving in both cases patients. In both cases we use two different general therapy formula according to literature (Azitromycin x Doxyhexal). In one case report, we found distinctive non-compliance during aftercare on our department with serious consequences.
The purpose of our report is to point out ocular complications of rosacea and importance of oftalmologist´s and dermatologist´s cooperation during therapy of this illness with can lead to permanent damage of front segment of the eye and significant loss of visual acuity.

References

  1. Abram, K., Silm, H., Maaroos, HI., et al.: Risk factors associated with rosacea. J Eur Acad Dermatol Venereol, 24; 2010: 565–571.
  2. Arman, A., Demirseren, DD., Takmaz, T.: Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline. Int J Ophthalmol, 8 (3); 2015: 544–549.
  3. Buddenkotte, J., Steinhoff, M.: Recent advances in unde - rstanding and managing rosacea. Br J Dermatol, 181 (1); 2019: 65-79.
  4. Deepika, D., Chintan, M., Arun, KJ.: Ocular rosacea – a review. US Ophthalmic Review, 10 (2); 2017: 113–8.
  5. De Marchi, SU., Cecchin, E., De Marchi, S.: Ocular rosacea: an underdiagnosed cause of relapsing conjunctivitis-blepharitis in the elderly. BMJ Case Rep, 2014
  6. Elewski, BE., Draelos, Z., Dréno, B., et al.: Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol, 25 (2); 2010: 188-200.
  7. Gether, L., Overgaard, LK., Egeberg A. et al.: Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 179 (2); 2018: 282–289.
  8. Hua, TC.: Cardiovascular comorbidities in patient with rosacea: a nationwide case control study from Taiwan. J Am Acad Dermatol, 73; 2015: 249–255.
  9. Nevoralová, Z.: Léčba rosacey. Remedia, 27; 2017: 219–225.
  10. Powell, FC.: Clinical practice. Rosacea. N Engl J Med, 352 (8); 2005: 793–803.
  11. Rainer, BM., Fisher, AH., Luz Felipe da SD. et al.: Rosacea is associated with chronic systemic dis eases in a skin severity dependent manner: results of a case control study. J Am Acad Dermatol, 734; 2015: 604–608.
  12. Sannino, M., Lodi, G., Dethlefsen, MW. et al.: Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3. Clin Case Rep, 6 (12); 2018: 2385–2390.
  13. Esther, JvZ.: Rosacea. N Engl J Med, 377; 2017: 1754-1764
  14. Vieira, AC., Höfling-Lima, AL., Mannis, MJ.: Ocular rosacea review. Arq Bras Oftalmol, 75 (5); 2012: 363-9.